@article{f6e693f1e97c4133bd112073a09b1bf2,
title = "The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs",
keywords = "ankylosing spondylitis, axSpA, biologics, extra-musculoskeletal manifestations, guideline, inflammatory bowel disease, management, psoriasis, recommendations, targeted synthetic DMARDs, treatment, uveitis",
author = "Zhao, \{Sizheng Steven\} and Harrison, \{Stephanie R.\} and Ben Thompson and Max Yates and Joe Eddison and Antoni Chan and Nick Clarke and Nadia Corp and Charlotte Davis and Lambert Felix and Kalveer Flora and Gregory, \{William J.\} and Jones, \{Gareth T.\} and Lamb, \{Christopher A.\} and Helena Marzo-Ortega and Murphy, \{Daniel J.\} and Harry Petrushkin and Virinderjit Sandhu and Raj Sengupta and Stefan Siebert and \{Van Der Windt\}, \{Danielle A.\} and Dale Webb and Yiu, \{Zenas Z.N.\} and Karl Gaffney",
note = "Data availability: All data are provided in online Supplementary Materials, available at Rheumatology online. Funding: S.S.Z. was supported by a National Institute for Health and Care Research (NIHR) Clinical Lectureship and works in centres supported by Versus Arthritis (grant no. 21173, 21754 and 21755) and the NIHR Manchester Biomedical Research Centre (NIHR203308). C.A.L. was supported by the NIHR Newcastle Biomedical Research Centre. H.M.O. was supported by the NIHR Leeds Biomedical Research Centre (Leeds BRC). Z.Y. was supported by a Medical Research Council Clinician Scientist Fellowship (MR/Z504026/1). The views expressed are those of the authors and not necessarily those of the National Health Service (NHS), the NIHR or the Department of Health. L.F., N.C., D.v.d.W. were funded by the BSR to perform the literature review.",
year = "2025",
month = jun,
doi = "10.1093/rheumatology/keaf089",
language = "English",
volume = "64",
pages = "3242--3254",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "Oxford University Press",
number = "6",
}